Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area jak stat signaling jak2'

Search results for: 'research area jak stat signaling jak2'

Items 21-30 of 87

Page
per page
  1. SB202190 (FHPI)
    A1632 SB202190 (FHPI)
     5 Citation
    Target: p38
    Summary: P38 MAPK inhibitor
  2. U0126-EtOH
    A1337 U0126-EtOH
     10 Citation
    Target: MEK
    Summary: MEK1/2 inhibitor
      ≥21.33 mg/mL
  3. LY2228820
    A5566 LY2228820
     1 Citation
    Target: p38
    Summary: P38 MAP kinase inhibitor
      ≥30.65 mg/mL
  4. CC-930
    A3288 CC-930
    Target: JNK
    Summary: JNK inhibitor,potent and selective
      Soluble in DMSO
  5. Trametinib (GSK1120212)
    A3018 Trametinib (GSK1120212)
     7 Citation
    Target: MEK
    Summary: MEK1 and MEK2 inhibitor, potent and selective
      insoluble in H2O; insoluble in EtOH; ≥15.38 mg/mL
  6. CHIR-99021 (CT99021) HCl
    A8396 CHIR-99021 (CT99021) HCl
    Target: GSK-3
    Summary: GSK-3α/β inhibitor
      ≥25.1 mg/mL
  7. CHIR-99021 (CT99021)
    A3011 CHIR-99021 (CT99021)
     2 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive
      ≥23.27 mg/mL
  8. XAV-939
    A1877 XAV-939
     1 Citation
    Target: TNKS
    Summary: Tankyrase 1/2 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥15.62 mg/mL
  9. XL147
    A5112 XL147
    Target: PI3K
    Summary: PI3K inhibitor,selective and reversible
      ≥22.45 mg/mL
  10. TGX-221
    A2681 TGX-221
    Target: PI3K
    Summary: PI3Kβ inhibitor,potent,selective and ATP competitive
      insoluble in H2O; insoluble in EtOH; ≥68.7 mg/mL

Items 21-30 of 87

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 86item
Reversibility
  1. Reversible 4item
  2. Irreversible 1 item
Target
  1. Akt 4item
  2. PI3K 10item
  3. Raf 6item
  4. Aurora Kinases 1 item
  5. mTOR 6item
  6. Androgen Receptors 1 item
  7. FLT3 1 item
  8. GSK-3 5item
  9. P-glycoprotein (P-gp) 1 item
  10. VEGFR 3item
  11. PDGFR 1 item
  12. Phosphodiesterases (PDEs) 1 item
  13. p38 4item
  14. PKB 1 item
  15. JNK 2item
  16. MEK 4item
  17. PORCN 1 item
  18. FGFR 1 item
  19. Nrf2 1 item
  20. GABAB Receptors 1 item
  21. Smoothened 1 item
  22. STAT 5item
  23. EGFR 3item
  24. Hedgehog 1 item
  25. BMP and Other Activin Receptors 2item
  26. JAK 10item
  27. Syk 2item
  28. HSP90 1 item
  29. TNKS 1 item
  30. Toll-like receptors (TLRs) 1 item
  31. ERK 1 item
  32. PKC 3item
  33. Melanocortin (MC) Receptors 1 item
  34. Fatty-acid-binding proteins (FABPs) 1 item
  35. NO Donors / Precursors 1 item
  36. IL Receptors 1 item
  37. c-RET 1 item
  38. TYK2 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 3item
  3. Bladder Cancer 1 item
  4. Breast Cancer 19item
  5. Cancer 60item
  6. Cervical Cancer 2item
  7. Colon Cancer 8item
  8. Colon Carcinoma 1 item
  9. Colorectal Cancer 10item
  10. Glioblastoma 10item
  11. Glioma 3item
  12. HIV Infections 1 item
  13. Immunological Diseases 1 item
  14. Inflammatory Bowel Disease 1 item
  15. Leukemia 8item
  16. Liver Cancer 1 item
  17. Lung Cancer 7item
  18. Lymphoma 3item
  19. Melanoma 5item
  20. Multiple Myeloma 1 item
  21. Myelofibrosis 1 item
  22. Myeloma 1 item
  23. Neuroblastoma 2item
  24. Non-small Cell Lung Cancer 5item
  25. Ovarian Cancer 7item
  26. Pancreatic Cancer 9item
  27. Pancreatic Carcinoma 2item
  28. Prostate Cancer 11item
  29. Psoriasis 1 item
  30. Pulmonary Arterial Hypertension 1 item
  31. Pulmonary Fibrosis 1 item
  32. Renal Cancer 1 item
  33. Renal Cell Carcinoma 1 item
  34. Rheumatoid Arthritis 4item
  35. Thyroid Cancer 3item
  36. Type 2 Diabetes 2item